NEW YORK CITY, NY / ACCESS Newswire / March 25, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Neumora Therapeutics, Inc. ("Neumora" or "the Company") (NASDAQ:NMRA) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Neumora securities pursuant to the registration statement and prospectus issued in connection with the Company's September 15, 2023 initial public offering ("IPO").

image for news NMRA SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Neumora Therapeutics, Inc. Investors Have Opportunity to Lead Class Action Lawsuit!

NEW YORK, NY / ACCESS Newswire / March 25, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Merck & Co., Inc. ("Merck" or "the Company") (NYSE:MRK) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Merck securities between February 3, 2022 and February 3, 2025, both dates inclusive (the "Class Period").

image for news MRK INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Merck & Co., Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit!

Golf performance platform will utilize Garmin data to provide unique information to players for dialing in their game OLATHE, Kan. , March 25, 2025 /PRNewswire/ -- Garmin (NYSE: GRMN) today announced an integration with Clippd, a unique data-driven performance platform that helps golfers understand where and how they can improve their game.

image for news Garmin announces integration with Clippd to help golfers improve their game

Announcement marks first selection of the state-of-the-art avionics suite for the military training market OLATHE, Kan. , March 25, 2025 /PRNewswire/ -- Garmin (NYSE: GRMN) today announced its G3000® PRIME tandem integrated flight deck has been selected by Pilatus for its PC-7 MKX military training aircraft.

image for news Garmin G3000 PRIME selected for Pilatus PC-7 MKX military training aircraft

Partnership Expects to Deploy More than $4 Billion into On-Lease Narrowbody Aircraft Partnership Expects to Deploy More than $4 Billion into On-Lease Narrowbody Aircraft

image for news FTAI and One Investment Management Partner on Inaugural Strategic Capital Partnership

TechnipFMC Wins Contract for Johan Sverdrup Phase 3 Development — Positive

FTI   Zacks Investment Research — March 25, 2025

FTI secures a key iEPCI contract for the Johan Sverdrup Phase 3 project, providing subsea systems to enhance production and support sustainable energy goals.

image for news TechnipFMC Wins Contract for Johan Sverdrup Phase 3 Development

Best Value Stocks to Buy for March 25th — Positive

FCCO  NXT  ONEW   Zacks Investment Research — March 25, 2025

ONEW, FCCO and NXT made it to the Zacks Rank #1 (Strong Buy) value stocks list on March 25, 2025.

image for news Best Value Stocks to Buy for March 25th

KEARNEY, Neb.--(BUSINESS WIRE)--The Buckle, Inc. Reports Quarterly Dividend and Announces the Appointment of Justin D. Ellison as Vice President of Information Security.

image for news The Buckle, Inc. Reports Quarterly Dividend and Announces the Appointment of Justin D. Ellison as Vice President of Information Security

SHANGHAI, China, March 25, 2025 (GLOBE NEWSWIRE) -- Qifu Technology, Inc. (NASDAQ: QFIN; HKEx: 3660) (“Qifu Technology” or the “Company”), a leading AI-empowered Credit-Tech platform in China, today announced a proposed offering (the “Notes Offering”) of convertible senior notes in an aggregate principal amount of US$600 million due 2030 (the “Notes”), subject to market conditions and other factors, only to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). The Company intends to grant the initial purchasers in the Notes Offering an option to purchase up …

image for news Qifu Technology, Inc. Announces Proposed Offering of US$600 Million Cash-par Settled Convertible Senior Notes

DXP Enterprises: A Solid Long-Term Buy With An Intact Bullish Outlook — Positive

DXPE   Seeking Alpha — March 25, 2025

DXPE saw a 15.7% YoY revenue growth in Q4 2024, driven by acquisitions and a 62% surge in the IPS segment. The company's adjusted EBITDA margin grew by 40 bps to 10.7%, with adjusted EPS beating estimates at $1.38. Strong demand in the IPS segment, especially in water and energy, is expected to drive growth in 2025 despite some headwinds in the SCS segment.

image for news DXP Enterprises: A Solid Long-Term Buy With An Intact Bullish Outlook

Wiping The Blood From Fluence Energy's Face; Time To Buy Again — Neutral

FLNC   Seeking Alpha — March 25, 2025

Fluence Energy's stock has plummeted after announcing significantly worse-than-expected Q1 2025 results and slashing FY 2025 guidance. Q1 2025 results showed a significant revenue and earnings miss; yet, gross profit margins improved, and backlog orders reached a record $5.1B. Despite short-term headwinds, FLNC still anticipates substantial revenue growth for FY 2025 and FY 2026.

image for news Wiping The Blood From Fluence Energy's Face; Time To Buy Again

The Nasdaq Composite (^IXIC 2.27%) is making its way back up after falling into correction territory, and as of Monday's close, it's down almost 6% this year. That's an average of about 2,500 stocks, so some are doing much better, and some are doing much worse.

image for news Nasdaq Correction: 1 Magnificent Stock Down 20% From Highs to Buy Now and Hold Forever

DUBLIN, Ohio , March 25, 2025 /PRNewswire/ -- Cardinal Health (NYSE: CAH) plans to release third-quarter financial results for its fiscal year 2025 on May 1, prior to the opening of trading on the New York Stock Exchange. The company will webcast a discussion of these results beginning at 8:30 a.m.

image for news Cardinal Health to Announce Third-Quarter Results for Fiscal Year 2025 on May 1

RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and Jiangsu Hengrui Pharmaceuticals Co., Ltd. (“Hengrui Pharma”), a global pharmaceutical company focused on scientific and technological innovation, today announced that the companies have entered into an exclusive license agreement for HRS-5346, an investigational oral small molecule Lipoprotein(a), or Lp(a), inhibitor currently being evaluated in a Phase 2 clinical trial in China. “Elevate.

image for news Merck Enters Exclusive License Agreement for HRS-5346, an Investigational Oral Lipoprotein(a) Inhibitor, for Cardiovascular Disease from Jiangsu Hengrui Pharmaceuticals Co., Ltd.

The outcome of a Russian prosecutor asking Shell to pay Gazprom 1.5 billion euros ($1.62 billion) for alleged unpaid gas deliveries in 2022 is "uncertain", Shell said in its annual report published on Tuesday.

image for news Shell says outcome of Russian claim for 1.5 billion euros 'uncertain'

Shell Set to Focus on LNG as Part of Future Growth Strategy — Negative

SHEL   Zacks Investment Research — March 25, 2025

SHEL is expected to focus on LNG with its demand set to surge in the future, balancing investor concerns and climate risks.

image for news Shell Set to Focus on LNG as Part of Future Growth Strategy

VANCOUVER, BC , March 25, 2025 /PRNewswire/ - Trilogy Metals Inc. (TSX: TMQ) (NYSE American: TMQ) ("Trilogy Metals", "Trilogy" or "the Company") is providing an update on the Ambler Access Project (the "Ambler Road") - the proposed 211-mile, industrial-use-only road from the Upper Kobuk Mineral Projects to the Dalton Highway that would enable the advancement of exploration and development at the Ambler Mining District in Northwest Alaska, home to some of the world's richest known copper-dominant polymetallic deposits. On January 20, 2025, President Trump signed a comprehensive executive order titled "Unleashing Alaska's Extraordinary Resource Potential", instructing agency heads across the …

image for news Trilogy Metals Provides Update on President Trump's Executive Orders and Actions by Department of Interior Aimed at Advancing the Ambler Access Project in Alaska

Based on overall survival data observed in interim analysis in platinum-resistant ovarian cancer, Mural will not progress trial to final analysis

image for news Mural Oncology Provides Update on Phase 3 ARTISTRY-7 Trial of Nemvaleukin in Combination with KEYTRUDA® (pembrolizumab) in Patients with Platinum-Resistant Ovarian Cancer

Comstock Settles Strategic Commitments and Strengthens Balance Sheet — Neutral

LODE   GlobeNewsWire — March 25, 2025

VIRGINIA CITY, Nev., March 25, 2025 (GLOBE NEWSWIRE) -- Comstock Inc. (NYSE: LODE) (“Comstock,” “our” and the “Company”), today announced the timely completion of two successful settlements of prior outstanding strategic commitments. These commitments originated from prior acquisitions of foundational assets and intellectual property that have been instrumental in advancing Comstock's renewable fuels and metals businesses. Comstock has eliminated regular cash payments and reinforced its financial position to support the Company's long-term commercialization strategy.

image for news Comstock Settles Strategic Commitments and Strengthens Balance Sheet

WAYNE, Pa., March 25, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced that new findings from the CLEAR study were presented at the 40th Annual European Association of Urology (EAU) Congress in Madrid, which took place March 21-24, 2025. Among the results, the study showed better early patient satisfaction and sexual function with the UroLift™ System (PUL) compared to Rezūm™ Water Vapor Therapy (WVTT).1

image for news Teleflex Announces Updated Clinical Study Data Presented at the European Association of Urology (EAU) Congress